Other recognised side effects include: Fatigue and dizziness, particularly during the initial weeks of treatment Headache, classified as 'common' in product information Hypoglycaemia (low blood sugar), primarily a risk in patients also taking insulin or sulfonylureas
If I have a patient who developed psoriasis after they became overweight or obese, then I am optimistic when prescribing a GLP-1 that, with weight loss, their psoriasis will go into remission. How Soon Will GLP-1s Lessen Psoriasis Symptoms
The timing of this publication is important, because the Trump administrations decision to block Medicare coverage for weight loss indications isnt just a policy disagreement, its a direct contradiction of the evidence base these veterans just helped build
Despite the SAD and MAD studies being conducted in different geographies and ethnicities, a single 5-mg dose of CT-388 resulted in similar plasma exposures and weight loss across both SAD and MAD studies, indicating the drug effects are unlikely to be significantly impacted by geographic, racial, or ethnic differences
phenotypic susceptibility testing to confirm resistance patterns
In addition, this study was conducted at a single center, which may limit the generalizability of the research results to a wider population with different demographic or clinical characteristics
